|
WO2019200120A1
|
|
Dihydroisoquinoline-2(1h)-carboxamide and related compounds and their use in treating medical conditions
|
|
WO2019164788A1
|
|
Methods of treating cancer using aryl dihydro-2h-benzo[b] [1,4]oxazine sulfonamide compounds
|
|
WO2019040842A1
|
|
Treatment of cancer using aryl dihydro-2h-benzo [b] [1,4] oxazine sulfonamide compounds
|
|
WO2018165501A1
|
|
INDOLINYL SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATMENT OF DISEASE
|
|
WO2018039539A1
|
|
Indazolyl-l,2,4-thiadiazolamines and related compounds for inhibition of rho-associated protein kinase and the treatment of disease
|
|
CA2987289A1
|
|
Aryl dihydro-2h-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of ror.gamma. and treatment of disease
|
|
CA2982847A1
|
|
Dihydro-2h-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of ror.gamma. and the treatment of disease
|
|
US2018093978A1
|
|
Indazolyl thiadiazolamines and related compounds for inhibition of Rho-associated protein kinase and the treatment of disease
|
|
US2017190659A1
|
|
Benzenesulfonamido and related compounds for use as agonists of RORγ and the treatment of disease
|
|
WO2015171610A2
|
|
Tetrahydroquinoline sulfonamide and related compounds for use as agonists of rory and the treatment of disease
|
|
AU2015222917A1
|
|
Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma and related therapeutic methods
|
|
CA2931792A1
|
|
N-substituted pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
|
|
WO2015089149A1
|
|
Trifluoromethyl pyrazolyl guanidine f1fo-atpase inhibitors and therapeutic uses thereof
|
|
CA2931850A1
|
|
Alkylpyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
|
|
US2015119439A1
|
|
Saturated acyl guanidine for inhibition of F1F0-ATPase
|
|
US2015148373A1
|
|
Heterocyclic guanidine F1F0-atpase inhibitors and therapeutic uses thereof
|
|
EP2866796A1
|
|
Indazole guanidine f1f0-atpase inhibitors and therapeutic uses thereof
|
|
US2015133437A1
|
|
Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease
|
|
AU2013259904A1
|
|
Bicyclic sulfone compounds for inhibition of RORy activity and the treatment of disease
|
|
CN103458886A
|
|
Pyridonyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof
|
